Get the Stockscreener App
6.55
4.97%
0.31
After Hours:
6.23
-0.32
-4.89%
Septerna Inc stock is traded at $6.55, with a volume of 312.44K.
It is up +4.97% in the last 24 hours and up +18.02% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.
See More
Previous Close:
$6.24
Open:
$6.22
24h Volume:
312.44K
Relative Volume:
0.57
Market Cap:
$290.84M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.82%
1M Performance:
+18.02%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$6.22
$6.625
1-Week Range:
$6.11
$6.89
52-Week Range:
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
Compare SEPN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
6.55 | 290.84M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
512.52 | 131.61B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.36 | 73.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
619.97 | 37.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.44 | 32.81B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
266.26 | 28.62B | 3.81B | -644.79M | -669.77M | -6.24 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
Septerna Inc Stock (SEPN) Latest News
SEPN Investors Have Opportunity to Join Septerna, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc.SEPN - PR Newswire
Septerna, Inc. (SEPN): Among Top Insider Purchases Last Month - Insider Monkey
Top 10 Insider Purchases Last Month - Insider Monkey
Director Makes Bold Move with Major Stock Purchase in Septerna, Inc. - TipRanks
Septerna director Alan Ezekowitz buys $515,934 in common stock By Investing.com - Investing.com Canada
Septerna director Alan Ezekowitz buys $515,934 in common stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Shareholders to Reach Out - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Septerna, Inc. (SEPN): Among The Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
10 Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist - TipRanks
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Shareholders to Inquire about Securities Investigation - Markets Insider
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Septerna, Inc. (SEPN) And Encourages Investors to Connect - Markets Insider
Top Executives at Septerna, Inc. Make Bold Stock Purchases! - TipRanks
Septerna CEO Jeffrey Finer acquires $96,960 in stock By Investing.com - Investing.com Australia
Septerna CEO Jeffrey Finer acquires $96,960 in stock - Investing.com India
Septerna CFO Labrucherie buys $56,866 in common stock By Investing.com - Investing.com South Africa
Septerna CFO Labrucherie buys $56,866 in common stock - Investing.com India
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Stockholders to Inquire about Securities Investigation - Markets Insider
Major Investment Alert: Third Rock Ventures Boosts Stake in Septerna, Inc. - TipRanks
Third Rock Ventures purchases $113,147 in Septerna stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Septerna to Present at TD Cowen 45th Annual Health Care Conference - The Manila Times
Can Septerna's Revolutionary GPCR Platform Disrupt Drug Discovery? CEO Presents Next Week - StockTitan
Third Rock Ventures acquires $6.17 million in Septerna shares By Investing.com - Investing.com Australia
Major Investment Alert: Septerna, Inc. Gains a Boost from Third Rock Ventures! - TipRanks
Septerna, Inc. (SEPN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Third Rock Ventures acquires $6.17 million in Septerna shares - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Septerna, Inc. (SEPN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Cantor Fitzgerald Expects Higher Earnings for Septerna - Defense World
Septerna CFO Gil Labrucherie acquires $172,296 in common stock By Investing.com - Investing.com Australia
SEPTERNA ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Septerna CFO Gil Labrucherie acquires $172,296 in common stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages Septerna, Inc. (SEPN) Investors to Inquire about Securities Investigation - Markets Insider
Septerna plunges as safety concerns force an end to early-stage trial - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Septerna, Inc. (SEPN) And Encourages Investors to Reach Out - Markets Insider
Kirby McInerney LLP Announces Investigation Against Septerna, Inc. (SEPN) on Behalf of Investors - GlobeNewswire
Septerna Inc Stock (SEPN) Financials Data
There is no financial data for Septerna Inc (SEPN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Septerna Inc Stock (SEPN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ezekowitz Alan | Director |
Mar 06 '25 |
Buy |
6.00 |
41,355 |
248,130 |
104,101 |
| Ezekowitz Alan | Director |
Mar 05 '25 |
Buy |
5.82 |
37,835 |
220,260 |
62,746 |
| Ezekowitz Alan | Director |
Mar 04 '25 |
Buy |
6.35 |
7,491 |
47,544 |
24,911 |
| Finer Jeffrey | CEO and President |
Feb 25 '25 |
Buy |
5.68 |
10,000 |
56,765 |
764,907 |
| Finer Jeffrey | CEO and President |
Feb 26 '25 |
Buy |
5.70 |
4,000 |
22,796 |
768,907 |
| Finer Jeffrey | CEO and President |
Feb 27 '25 |
Buy |
5.80 |
3,000 |
17,400 |
771,907 |
| Labrucherie Gil M | Chief Financial Officer |
Feb 25 '25 |
Buy |
5.59 |
6,282 |
35,116 |
36,282 |
| Labrucherie Gil M | Chief Financial Officer |
Feb 27 '25 |
Buy |
5.85 |
3,718 |
21,750 |
40,000 |
| Third Rock Ventures VI, L.P. | 10% Owner |
Feb 24 '25 |
Buy |
6.00 |
18,861 |
113,147 |
4,211,659 |
| Third Rock Ventures VI, L.P. | 10% Owner |
Feb 20 '25 |
Buy |
5.92 |
612,674 |
3,627,030 |
3,765,130 |
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):